IsoRay Inc. (NYSEMKT:ISR)’s Cesium 131 cancer therapy is FDA approved, and superior to any cancer therapy by many measures, like the unmatched high 98% to 100% efficacy rate. IsoRay, Inc. (NYSEMKT:ISR) shares after opening at $0.90 moved to $1.15 on last trade day and at the end of the day closed at $1.11. Company price to sales ratio in past twelve months was calculated as 9.27 and price to cash ratio as 9.69. IsoRay, Inc. (NYSEMKT:ISR) showed a positive weekly performance of 37.04%.
Covidien plc (NYSE:COV) is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. Covidien plc (NYSE:COV) shares fell -0.50% in last trading session and ended the day on $70.26. COV return on equity ratio is recorded as 21.40% and its return on assets is 10.20%. Covidien plc (NYSE:COV) yearly performance is 22.90 %.
Medical equipment supplier Unilife Corporation (NASDAQ:UNIS) has bucked the negative sentiment after announcing they had secured $US60 million of debt funding. Unilife Corp (NASDAQ:UNIS) shares moved down -3.81% in last trading session and was closed at $4.80 while trading in range of $4.75 – $4.94 – Unilife Corp (NASDAQ:UNIS) year to date (YTD) performance is 9.09%.
Alphatec Holdings Inc (NASDAQ:ATEC) is cheap and acts in the growing spine surgery segment which is helped both by the aging trend and the obesity trend. Alphatec Holdings Inc (NASDAQ:ATEC) weekly performance is 10.32%. On last trading day company shares ended up $1.39. Alphatec Holdings Inc (NASDAQ:ATEC) distance from 50-day simple moving average (SMA50) is -26.40%. Analysts mean target price for the company is $2.74.
Leave a Reply